Group Health Insurance for 750 Employees
Group Health Insurance for 750 Employees
Jason Stolz CLTC, CRPC
Group health insurance for 750 employees is an enterprise-scale decision where healthcare benefits directly influence operating margins, talent strategy, and long-term financial planning. At this size, pricing is almost entirely experience-based. Carriers and program partners analyze multi-year claims data, pharmacy utilization patterns, specialty drug exposure, chronic condition prevalence, and care access behavior with precision — meaning plan design, funding structure, and ongoing governance matter as much as, and often more than, the carrier name itself. Organizations with 750 employees often discover that legacy approaches — especially fully insured models selected for their simplicity — become progressively inefficient as the workforce stabilizes and claims history becomes statistically reliable. Premiums rise regardless of actual performance, transparency remains limited, and leadership lacks the consistent, decision-grade reporting needed to manage costs proactively rather than reactively at each renewal cycle.
The strategic advantage at 750 employees is leverage: sufficient data volume, workforce stability, and buying power to build a plan that controls costs through design and governance rather than simply accepting whatever the renewal brings. At Diversified Insurance Brokers, we help employers at this scale redesign group health insurance to improve predictability, increase transparency, and support sustainable enterprise growth without reducing the benefit quality that drives recruitment and retention. This page covers the enterprise funding models most commonly used at 750 employees, the cost drivers that matter most at this scale, and the governance practices that transform health benefits from an unpredictable annual expense into a managed financial system. For broader context on how group medical coverage is priced at different employer sizes, our resource on group medical insurance provides useful framing.
Enterprise Group Health Strategy Review (750 Employees)
We’ll evaluate your current plan, claims performance, funding structure, and renewal exposure to identify opportunities for cost control and long-term stability.
Request an Enterprise Health ReviewWhy Group Health at 750 Employees Is an Enterprise System
Group health insurance at 750 employees is fully experience-rated in practical terms. Underwriters and plan administrators assess utilization trends, chronic condition burden, high-cost claimant frequency, specialty drug dynamics, site-of-care patterns, and care access behavior with statistical depth that simply does not exist at smaller group sizes. At this scale, inefficiencies that might be invisible in a smaller group — a network that routes employees into unnecessarily expensive care settings, an unmanaged specialty pharmacy program, a chronic condition population without coordinated support — can translate into seven-figure annual overspend when multiplied across a larger enrolled population.
The most important strategic shift at 750 employees is that healthcare becomes a system you can actively manage rather than a cost you passively accept. You can measure utilization outcomes against benchmarks. You can negotiate vendor terms from a position of meaningful leverage. You can implement targeted programs — pharmacy management, care navigation, site-of-care optimization — that are large enough in a 750-person population to generate measurable cost impact rather than statistical noise. The organizations that treat healthcare as a managed system rather than an annual renewal event consistently produce better long-term financial outcomes and more stable employee benefit experiences than those that remain in a reactive renewal cycle regardless of the carrier they choose.
How Enterprise Pricing Works at This Scale
At 750 employees, pricing is not a blended market average applied generically to your headcount. It is a direct reflection of your organization’s own claims history, utilization patterns, and plan architecture — modified by the funding structure you use to access and share that risk. Carriers and administrators analyze what your population looks like, how care is accessed, what your network unit costs reflect, where pharmacy spend is trending, and how frequently catastrophic individual claims appear. That analysis is what determines both the cost of coverage and the leverage you have in negotiating favorable terms.
This reality is what makes fully insured models feel increasingly frustrating at enterprise scale. Fully insured pricing includes risk margins, administrative loads, and profit components that do not reflect your organization’s actual performance — and even when your claims experience is favorable, those built-in components persist regardless of whether your plan “performed well” in any given year. Enterprise organizations that understand this dynamic want a structure that improves transparency and aligns actual cost with actual performance, creating a financial incentive for good plan governance that fully insured models structurally cannot provide. The right question is not “Which carrier is cheapest?” The right question is “Which funding structure gives us the best combination of long-term cost control, visibility into what is driving spend, and financial predictability across planning horizons?”
Funding Options for Group Health at 750 Employees
Organizations at 750 employees have access to all major group health funding structures, and the differences between those structures — in cost transparency, employer financial exposure, renewal predictability, and governance capacity — are substantial. Choosing the right funding model is one of the highest-leverage decisions in enterprise health benefits because it determines not just how premiums are structured but how much data the employer has access to, how much control can be exercised over plan design, and how directly favorable or unfavorable claims performance is reflected in what the organization actually pays.
For organizations evaluating whether their current fully insured structure remains competitive as they approach enterprise scale, understanding why self-funding becomes increasingly standard as group size increases is clarifying. Our resources on what self-funded group health insurance is, the pros and cons of self-funded group health, and minimum employees for group health insurance provide the structural context for why funding model selection at this scale has compounding long-term financial implications.
Fully Insured Plans at 750 Employees: Where the Model Underperforms
Fully insured plans remain available and are occasionally appropriate at 750 employees — particularly when an organization wants complete risk transfer to the carrier, lacks internal capacity for governance, or has a claims profile that makes self-funding unattractive from a risk management perspective. The challenge is that for most enterprise-scale employers with a reasonably stable workforce and predictable claims history, the fully insured model imposes structural costs that are difficult to recover.
The premium includes risk loads, administrative margins, and profit that persist regardless of whether the group’s actual experience justifies them. Transparency is limited: employers typically receive consolidated renewal communications rather than granular claims data that would allow identification of specific cost drivers. The feedback loop between plan performance and premium is weak — favorable experience in a given year may contribute modestly to a slightly better renewal, but the employer never receives the full financial benefit of good performance the way they would in a self-funded structure where savings stay in the plan. Over a multi-year horizon, this structural inefficiency compounds, producing a systematic transfer of value from the employer to the carrier that is not obvious in any single year’s renewal but becomes significant when viewed across time. Leadership that feels like costs increase without clear explanations, or that experiences the “shop carriers hoping for a better renewal” cycle without improving underlying cost drivers, is often experiencing the natural consequence of remaining fully insured at a scale where better alternatives are readily available.
Self-Funded Group Health Insurance for 750 Employees
Self-funding is the most common enterprise-scale funding model for organizations at 750 employees because it addresses the core structural limitations of the fully insured approach: it creates direct alignment between claims performance and cost, provides meaningful data transparency for governance, and eliminates the built-in carrier margins that make fully insured pricing increasingly inefficient as group size grows. In a self-funded structure, the employer funds claims as they occur, with a third-party administrator (TPA) or administrative services-only (ASO) arrangement handling plan operations, provider network management, and member services. Stop-loss insurance protects against large individual claims through specific deductibles and against aggregate annual volatility through aggregate attachment points, creating a defined financial ceiling on worst-case annual exposure.
The fundamental benefit of this structure is control through transparency. Employers gain access to actual claims data — pharmacy utilization, medical spend by category, network unit cost performance, high-cost claimant trends, site-of-care patterns — that enables targeted intervention rather than reactive wholesale plan changes. That visibility is what makes meaningful governance possible: instead of discovering at renewal what drove cost increases and having limited options to address them, leadership can track cost dynamics throughout the year and make smaller, more targeted adjustments that address specific drivers before they compound into renewal pressure. Self-funding is not a “bet” that employees will not have health events. It is a structure that uses transparency, vendor accountability, and defined financial guardrails to control what can be controlled while protecting against what cannot be predicted.
Stop-Loss Strategy at Enterprise Scale
Stop-loss insurance is the mechanism that converts the variable cost exposure of self-funding into a defined, manageable financial commitment. At 750 employees, stop-loss decisions should be made strategically rather than selected from a default menu, because the attachment points, contract terms, and coverage design materially affect both the employer’s annual cost structure and the degree of renewal stability that the plan can sustain over time.
Specific stop-loss caps the employer’s financial exposure for any single claimant’s claims within a plan year — when a covered individual’s paid claims exceed the specific deductible, the stop-loss carrier reimburses claims above that threshold. This protection is essential for managing the impact of catastrophically expensive individual events — cancer treatment, complex surgical cases, neonatal intensive care, specialty drug therapies — that would otherwise create severe budget disruption if the employer absorbed the full cost. Aggregate stop-loss caps total annual plan spending across all claimants as a percentage of expected claims, providing a ceiling on total exposure in years where multiple high-cost events occur simultaneously. Together, these two layers define the employer’s worst-case annual healthcare cost boundary with reasonable precision, converting an open-ended variable cost into a managed financial commitment.
At enterprise scale, the right stop-loss structure also considers factors beyond pure financial protection: the contract terms governing how prior authorization and coordination interact with stop-loss reimbursement, how the stop-loss carrier handles large ongoing claims that span multiple plan years, and how aggregate attachment points are calculated in ways that remain favorable as the plan grows or the enrolled population composition changes.
Hybrid and Partially Self-Funded Structures
Some 750-employee organizations prefer hybrid funding structures that blend the predictability of level-funded monthly payments with the transparency and potential savings of self-funding. These models provide more consistent cash flow profiles than pure self-funding while preserving the upside from favorable claims performance and the data access that enables meaningful governance. Level-funded arrangements at this scale often include enhanced reporting packages, pharmacy strategy integration, and targeted care management programs as part of the administrative structure, creating a pathway toward more sophisticated governance without requiring a full administrative infrastructure rebuild in a single transition.
Hybrid structures are also appropriate as transitional models for organizations moving deliberately from fully insured coverage toward full self-funding over a defined period — managing the transition in a staged way that allows time to build internal governance capacity, establish reporting cadences, and develop confidence with the self-funded model before assuming full stop-loss responsibility. The right structure depends on the organization’s current data maturity, governance capacity, and tolerance for year-to-year cost variability relative to the financial upside of full self-funding. There is no universal answer, but there is a clearly superior process: evaluating the alternatives honestly against the organization’s specific profile rather than defaulting to the most familiar option.
Compare Enterprise Group Health Options
Compare fully insured, partially self-funded, and self-funded strategies for a 750-employee organization.
Compare Funding StrategiesThe Primary Cost Levers at 750 Employees
Sustainable cost reduction at enterprise scale does not typically come from benefit cuts or large employee contribution shifts. These approaches create false savings — employees delay necessary care, dissatisfaction affects recruitment and retention, participation patterns shift in ways that change the enrolled population’s risk profile, and costs can rebound in more expensive ways than the original savings justified. Genuine enterprise savings at 750 employees come from structural improvements in how the plan works: network strategy, pharmacy management, site-of-care optimization, care navigation, and vendor accountability.
Network strategy influences the unit costs the plan pays for equivalent services across the full spectrum of care. Two plans with identical benefit designs can produce substantially different total claims costs because their underlying network contracts negotiate different prices with the same providers for the same services. At enterprise scale, network strategy should be intentional — based on where employees actually live and receive care, optimized for the care settings that generate the highest volume of the plan’s spending, and reviewed for alignment between the network’s geographic coverage and the enrolled population’s actual geographic distribution. An employee population concentrated in specific markets may be better served by a focused network with strong unit cost performance in those markets than by a broad national network that includes irrelevant coverage breadth at the expense of pricing discipline in the markets that actually matter.
Specialty pharmacy management is frequently the single largest cost lever available at 750 employees. Specialty medications — biologics, oncology drugs, gene therapies, specialty infusions — can individually consume a disproportionate share of the total pharmacy budget even when only a small percentage of enrolled members use them. Without a dedicated specialty pharmacy management strategy, a small number of medications can drive cost volatility that overwhelms savings from every other plan management initiative combined. Effective specialty pharmacy management addresses formulary design, specialty pharmacy channel stewardship, prior authorization processes that ensure clinical appropriateness, manufacturer rebate optimization, and coordination with the pharmacy benefit manager’s specialty program. The goal is not to restrict clinically necessary medications — those should be accessible and appropriately supported — but to ensure they are obtained through the most cost-efficient channels, at the most competitive net prices, with appropriate clinical oversight that avoids unnecessary waste.
Site-of-care optimization addresses one of the most common and most correctable sources of unnecessary spending in employer health plans: employees routinely accessing equivalent services in expensive settings when lower-cost settings with comparable quality are available. Routine imaging performed in hospital outpatient departments rather than independent imaging centers, outpatient procedures in hospital facilities rather than ambulatory surgery centers, specialist consultations in hospital-affiliated practices rather than independent practices — each of these represents a systematic cost premium that accumulates across a 750-person population into material annual overspend. Effective site-of-care programs guide employees toward appropriate settings through benefit design differentials, care navigation support, and transparency tools — not by restricting access but by making the cost-effective choice the easiest and most financially obvious choice.
Analytics, Transparency, and Accountability
Enterprise plans unlock actionable claims data that smaller groups simply do not produce. With the right reporting cadence — typically monthly for operational tracking and quarterly for strategic review — employers at 750 employees can identify utilization trends with enough lead time to respond before they compound into renewal pressure, evaluate vendor performance against contractual commitments and market benchmarks, and continuously improve the plan’s financial performance through incremental targeted interventions rather than disruptive annual redesigns.
The value of analytics at this scale is not in the data volume itself — it is in the operational decisions the data enables. Effective enterprise reporting answers the practical questions that leadership needs: Where is spend growing fastest? Is the growth concentrated in specific conditions, specific providers, or specific employee segments? Are our vendor partners delivering what we contracted and what we paid for? What early indicators suggest emerging cost risk that we can address now? Which plan design elements are working as intended and which are producing unintended utilization behavior? These questions have answers in the data that a self-funded plan with good analytics produces — and organizations that build the governance capacity to use those answers consistently outperform those that collect data without acting on it.
Governance: Transforming Benefits Into a Managed System
At enterprise scale, governance is the discipline that converts theoretical advantages of self-funding into realized financial outcomes. Governance does not require complexity or large internal staff — it requires consistency and accountability. A structured quarterly review cadence covering major cost driver trends, vendor performance against benchmarks, and emerging risk indicators is often sufficient to create the proactive management posture that separates employers who steadily improve from those who manage from renewal to renewal without making progress.
Effective enterprise governance also aligns stakeholders across functions. HR focuses on employee experience and benefit communication. Finance focuses on cost predictability, budget alignment, and financial risk management. Leadership focuses on the strategic workforce implications of benefit design. When governance creates clear accountability for each of these dimensions — with consistent data, shared metrics, and regular review — the plan becomes genuinely manageable rather than a source of annual budget uncertainty. Well-governed plans also reduce the reactive pressure that leads to the most disruptive benefit changes: the large deductible increases, the significant contribution shifts, the carrier changes made under time pressure — all of which affect employee satisfaction and talent competitiveness in ways that outlast any single renewal cycle. Understanding the stop-loss mechanics that support this governance framework in detail is covered in our resource on understanding stop-loss insurance in level-funded plans.
Renewal Stability and Long-Term Planning
The ultimate goal of enterprise health benefit management at 750 employees is not to minimize cost in any single year — it is to create conditions where renewal outcomes are predictable, where management decisions are proactive rather than reactive, and where the plan continues to serve the organization’s talent and financial objectives consistently across multiple years. Predictable renewal outcomes support better financial planning, reduce the organizational disruption of last-minute benefit changes, and create a platform for consistently improving the plan rather than starting the redesign conversation from scratch at every renewal cycle.
Organizations that achieve this kind of renewal stability typically share a common pattern: they invested in the right funding structure for their scale, established governance processes that produce consistent data-driven decisions, built vendor accountability into their plan management, and made incremental improvements throughout the plan year rather than waiting for renewal to address accumulated issues. The path to that stability is rarely complicated in concept — it is simply the consistent application of the right structure, the right data, and the right governance discipline over time.
Planning Beyond 750 Employees
The strategy selected and implemented at 750 employees creates the foundation for how the organization manages healthcare as it grows further. Organizations that have established transparent, data-driven funding structures, effective vendor accountability frameworks, and consistent governance processes at this scale typically find that scaling to 1,000, 1,500, or more employees builds productively on what already exists rather than requiring a complete redesign. The infrastructure — the reporting cadences, the vendor relationships, the plan design philosophy — transfers and scales efficiently when it was built with good architecture. Those that delay building that infrastructure often find that cost patterns become more entrenched and harder to address as the group grows larger, because established utilization behaviors and embedded vendor arrangements become progressively more difficult to change without significant disruption.
Stabilize Enterprise Renewals for a 750-Employee Plan
We’ll review your funding model, reporting, and major cost drivers to identify practical ways to improve predictability without cutting benefits.
Request an Enterprise Health ReviewFinancial Protection Essentials
Enterprise group health strategy, self-funding, stop-loss, and workforce benefits planning resources.
Related Group Health Pages
Explore additional group health resources for small and growing employers.
Talk With an Advisor Today
Choose how you’d like to connect—call or message us, then book a time that works for you.
Schedule here:
calendly.com/jason-dibcompanies/diversified-quotes
Licensed in all 50 states • Fiduciary, family-owned since 1980
FAQ: Group Health Insurance for 750 Employees
Yes — employers with 750 employees qualify for the full range of group health insurance funding structures available in the market, including fully insured plans, level-funded designs, partially self-funded arrangements, and fully self-funded plans with stop-loss protection. At this size, the organization is fully experience-rated, meaning underwriting is based primarily on the group’s own claims history and utilization patterns rather than pooled market averages. This creates both a responsibility and an opportunity: the plan’s cost is substantially determined by how the organization manages it, which is why funding structure selection and ongoing governance are more important at 750 employees than at smaller group sizes where individual claims have less statistical impact on renewal outcomes.
Yes — self-funding or partially self-funded arrangements are the most common funding structures for organizations at 750 employees, and for good reason. At this size, the group has sufficient claims volume to be statistically meaningful, sufficient buying power to negotiate favorable stop-loss and vendor terms, and a large enough enrolled population for targeted interventions — pharmacy management, care navigation, site-of-care optimization — to generate measurable financial impact. Self-funding provides direct alignment between claims performance and cost, transparency into what is actually driving spend, and the ability to make plan design decisions based on the organization’s own data rather than on generic market assumptions. Fully insured plans remain available but are typically less cost-efficient at this scale because the carrier’s built-in risk margins and administrative loads represent a persistent cost that does not reflect the organization’s actual claims performance.
Financial risk in a self-funded plan at 750 employees is managed through two layers of stop-loss insurance that together create a defined maximum financial exposure for the organization. Specific stop-loss — also called individual stop-loss — caps the employer’s financial liability for any single claimant’s claims within the plan year. Once a covered individual’s paid claims exceed the specific deductible amount, the stop-loss carrier reimburses claims above that threshold, protecting the employer from the full impact of catastrophically expensive individual events. Aggregate stop-loss caps total annual plan spending across all claimants at a defined percentage of expected claims, providing a ceiling on total financial exposure in years where multiple high-cost events occur simultaneously. With both layers in place, the employer enters each plan year with a clearly defined worst-case cost boundary — converting what would otherwise be open-ended variable financial exposure into a managed financial commitment with predictable limits. The right specific deductible and aggregate attachment point depend on the organization’s financial profile, risk tolerance, and what level of year-to-year variability is acceptable relative to the long-term cost advantages of self-funding.
The most consistently significant cost drivers in an enterprise group health plan at 750 employees are specialty pharmacy, network unit costs, and site-of-care patterns. Specialty medications — biologics, oncology treatments, gene therapies, specialty infusions — can individually consume a disproportionate share of the total plan budget even when only a small percentage of enrolled members use them, making specialty pharmacy management one of the highest-impact levers available. Network unit costs — the prices the plan pays for equivalent services across the care spectrum — vary materially across network arrangements, and a network that is not optimized for the organization’s actual geographic and utilization profile can systematically overpay for care that could be obtained at equivalent quality through a more cost-efficient contracting structure. Site-of-care patterns determine whether employees access routine services in lower-cost settings — independent imaging centers, ambulatory surgery centers, urgent care — or default to hospital outpatient settings that command significantly higher facility fees for identical clinical services. Chronic condition management effectiveness also has a significant impact on long-term cost trajectory, because conditions that are poorly managed progress to more expensive acute events over time at a rate that is visible in claims data and addressable through targeted programs.
Enterprise health plan transitions at 750 employees typically require a planning and implementation window of three to six months from the decision to transition to the new plan’s effective date, depending on the complexity of the change and the quality of the organization’s existing claims data and vendor relationships. Transitions from fully insured to self-funded — which involve selecting a third-party administrator, establishing stop-loss insurance, negotiating network access arrangements, implementing reporting and analytics infrastructure, and communicating plan changes to employees — generally require the longer end of that range to execute well. Moving between self-funded arrangements or adjusting funding within an existing self-funded framework can often be completed more quickly. Organizations that begin the evaluation process at least 90 to 120 days before the intended effective date give themselves sufficient time for a thorough comparison, underwriting, implementation, and employee communication — all of which are necessary for the transition to produce the intended outcomes rather than introducing disruption alongside the cost improvements.
Yes — well-designed enterprise health plans are built to scale efficiently as enrollment grows, and organizations that establish strong governance infrastructure and appropriate funding structures at 750 employees typically find that growth beyond that level builds productively on what already exists. As enrollment increases, claims credibility improves further, vendor leverage increases, and the statistical foundation for data-driven governance becomes even more robust. The governance processes — quarterly claims reviews, vendor performance tracking, targeted intervention programs — transfer and scale with minimal redesign when they were built with the right architecture. The alternative, waiting until a larger size to invest in governance infrastructure, typically means inheriting entrenched cost patterns and established vendor arrangements that become progressively harder to change at scale without disruptive redesign. The transition is almost always easier and less expensive the earlier it is made.
Pharmacy management — particularly specialty pharmacy management — is frequently the single largest cost lever available to enterprise employers at 750 employees. Specialty drugs are high-cost, often long-duration therapies that can individually reach hundreds of thousands of dollars annually per patient, and their prevalence is growing as the pharmaceutical pipeline continues to produce new specialty treatments across oncology, autoimmune conditions, and rare diseases. Without active management, a small number of specialty medications can dominate the plan’s cost profile and create volatility that exceeds the impact of all other plan management initiatives combined. Effective pharmacy management at this scale addresses formulary design that encourages cost-effective therapeutic alternatives where clinically appropriate, specialty pharmacy channel stewardship that ensures medications are dispensed through arrangements that optimize net cost, prior authorization processes that confirm clinical appropriateness for high-cost therapies, manufacturer rebate programs that reduce net pharmacy cost, and benefit design that coordinates medical and pharmacy utilization in ways that reduce total cost of care rather than shifting costs between benefit categories. The goal throughout is appropriate access to necessary medications at the lowest net cost — protecting both the plan’s financial sustainability and the member’s clinical outcomes.
Effective governance for an enterprise health plan at 750 employees is built around consistency, accountability, and data-driven decision making rather than around complexity or large internal staff. A structured quarterly review cadence — covering major cost driver trends by category, vendor performance against contractual benchmarks, emerging high-cost claimant patterns, pharmacy utilization and specialty drug pipeline risk, and plan design performance — creates the proactive management posture that produces better long-term outcomes than reactive annual renewal management. Between quarterly reviews, monthly operational reporting on key metrics — total claims run rate, pharmacy spend trends, stop-loss claims status — provides the early warning signals that allow intervention before issues compound into renewal pressure. Vendor accountability is built into governance by establishing measurable performance expectations at the beginning of each contract period and reviewing performance against those expectations on a consistent schedule rather than relying on vendors to self-report favorable outcomes. When governance is structured this way, the plan becomes genuinely manageable — not perfect, but consistently improving and consistently predictable in ways that support sound financial planning and stable employee benefit experiences.
Sustainable cost reduction at enterprise scale almost never comes from benefit cuts or large contribution shifts — these approaches create false savings that are often more than offset by reduced employee satisfaction, changes in participation patterns, delayed care that produces more expensive downstream events, and talent competitiveness impacts. The most effective cost reduction strategies at 750 employees work by improving the efficiency of how the healthcare system operates for the enrolled population without degrading the benefit experience. Network optimization reduces the unit costs the plan pays for equivalent services. Pharmacy management reduces net pharmaceutical spend without restricting appropriate access. Site-of-care programs redirect utilization toward lower-cost settings that provide equivalent clinical quality. Care navigation supports employees in making informed decisions about when and where to access care, reducing avoidable emergency room utilization and inappropriate care settings. Chronic condition management programs identify and support high-risk employees earlier in the disease progression, when intervention is less expensive and more effective than managing acute deteriorations. When these strategies are implemented together within a self-funded structure with strong analytics, the result is a plan that costs less because it works better — not because it provides less.
Before selecting a group health plan structure and carrier at 750 employees, employers should be prepared to answer — and to ask — several foundational questions that determine whether the selection process will produce a genuinely better long-term outcome or simply a lower initial renewal number. On the internal side: What does our current claims data tell us about where our spend is concentrated and what is driving cost trends? What governance capacity do we have to actively manage a self-funded plan, and what support do we need to build that capacity? What is our financial tolerance for year-to-year cost variability versus our desire for maximum long-term cost control? What benefit design features are most important to our employee population and non-negotiable from a talent perspective? On the vendor side: What data will we have access to and how frequently? How does the stop-loss program handle prior authorization coordination and multi-year high-cost claims? What network performance guarantees exist and how are they measured? What pharmacy management programs are included and what specialty drug management capabilities exist? What reporting and analytics are available and how actionable are they for governance? How are vendor fees structured and are there performance-based components that align incentives with outcomes? Asking these questions before selecting rather than after committing produces better outcomes and avoids the discovery that the chosen structure cannot support the governance approach the organization needs.
About the Author:
Jason Stolz, CLTC, CRPC, DIA, CAA and Chief Underwriter at Diversified Insurance Brokers (NPN 20471358), is a senior insurance and retirement professional with more than 25 years of real-world experience helping individuals, families, and business owners protect their income, assets, and long-term financial stability. As a long-time partner of the nationally licensed independent agency Diversified Insurance Brokers, Jason provides trusted guidance across multiple specialties—including fixed and indexed annuities, long-term care planning, personal and business disability insurance, life insurance solutions, Group Health, and short-term health coverage. Diversified Insurance Brokers maintains active contracts with over 100 highly rated insurance carriers, ensuring clients have access to a broad and competitive marketplace.
His practical, education-first approach has earned recognition in publications such as VoyageATL, highlighting his commitment to financial clarity and client-focused planning. Drawing on deep product knowledge and years of hands-on field experience, Jason helps clients evaluate carriers, compare strategies, and build retirement and protection plans that are both secure and cost-efficient. Visitors who want to explore current annuity rates and compare options across multiple insurers can also use this annuity quote and comparison tool.
Explore More Group Health Insurance Options: Browse our complete guide to Group Health Insurance by Company Size — covering plans for 2, 10, 20, 50, 100, 250, 500, 750 & 1,000+ employees from 100+ carriers.
